IGC Pharma. has filed a patent for an analgesic composition to relieve various types of pain. The composition includes cannabis compounds, analgesic compounds like menthol and capsaicin, and other ingredients for pain relief without significant side effects. GlobalData’s report on IGC Pharma gives a 360-degree view of the company including its patenting strategy. Buy the report here.
Smarter leaders trust GlobalData
According to GlobalData’s company profile on IGC Pharma, Cancer treatment biomarkers was a key innovation area identified from patents. IGC Pharma's grant share as of January 2024 was 17%. Grant share is based on the ratio of number of grants to total number of patents.
A patent application (Publication Number: US20240009207A1) discloses an analgesic composition designed to alleviate acute and chronic pain. The composition includes three key components: cannabis compounds like CBD and THC, analgesic compounds such as histamine dihydrochloride, and a variety of additional ingredients like aloe vera, black pepper essential oil, and vitamins. The first component can consist of nano CBD and THC, synthetic CBD or THC isolate. The second component may include histamine dihydrochloride, salicylate, camphor, menthol, and more, while the third component comprises a mix of ingredients like aloe vera, black pepper essential oil, and phenoxyethanol.
Moreover, the patent application outlines a method for using this composition to relieve pain effectively. By administering the analgesic composition topically in the form of a cream, gel, lotion, ointment, or salve, individuals suffering from pain can experience relief. The method involves applying the composition to the affected area, potentially enhancing delivery through the use of a transdermal patch covered by an occlusive dressing. This innovative approach combines the benefits of cannabis compounds with analgesic ingredients to provide a comprehensive solution for pain management.
To know more about GlobalData’s detailed insights on IGC Pharma, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies across the world’s largest industries.
